Our mission is to make a meaningful difference in the lives of thousands of the most vulnerable infants through world class research and innovative products.
Prolacta Bioscience is a privately held, life sciences company dedicated to improving the quality of life in the most fragile infants through the harmony of nature and science. We create specialty formulations made from human milk for the nutritional needs of premature infants in neonatal intensive care units (NICU). These formulations are sold to NICUs around the country.
Prolacta developed the first large scale human milk processing facility in the world. Using state-of-the-art formulation, pasteurization and filling processes, we formulate human milk to an exact standard to meet the needs of very low birth weight babies during the first 30 days of life.
Prolacta is committed to supporting research in the study of human milk and premature infant nutrition in order to make a difference in the lives of the most fragile premature babies.
You’re dedicated to caring. We’re dedicated to you.
AngelEye Health has a deep understanding of the value that both family engagement and family-centered care bring to neonatal and pediatric care environments. We provide a complete HIPAA-compliant family engagement platform to integrate parents simply and seamlessly into the child’s care team. Our approach has a proven, positive impact on the quality of the family experience, care delivery workflows for the dedicated bedside team, and patient outcomes. From admission to discharge, AngelEye Health solutions impact all stakeholders along the journey to a successful transition home. AngelEye partners with more than 200+ hospitals in the US and EU boasting a 100% retention rate since our founding in 2013.
Interested In Being a Part of Our Industry Collective?
UCommunity – UPrinting Sponsorship Program supports the NICU Parent Network